BIOREGENX, INC.
Close on Oct 16, 2026
- Market cap
- $3.88M
- P/E (TTM)
- –
- Dividend yield
- –
About Bioregenx
Services-Computer Programming, Data Processing, Etc., SIC 7370
BioRegenx, Inc. researches, develops, and commercializes dietary supplements, medical devices, software, and contactless diagnostic technologies. Operating through subsidiaries including Microvascular Health Solutions, NuLife Sciences, DocSun Biomedical Holdings, and Findit AI Connect, its portfolio includes microvascular health supplements such as Endocalyx Pro, the GlycoCheck Class I medical device and software system, wellness and muscle stimulation therapy devices, and contactless vital-sign estimation software. The company serves healthcare practitioners, academic research institutions, hospitals, pharmacies, wellness centers, wholesale distributors, and individual consumers.
The company is headquartered in Chattanooga, Tennessee, with additional distribution handled out of Aberdeen, South Dakota. Its business operations, clinical studies, and academic partnerships span North America, Asia, and Europe. In addition, its technology distribution and licensing activities include international agreements covering regions such as China, Hong Kong, and Macao.
Summary of the business section of Bioregenx's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BIOREGENX, INC.
- Founded
- 1998
- Headquarters
- Chattanooga, TN
- Address
- 7407 Ziegler Road 37421
- Phone
- (866) 770-4067
- Website
- findit.com
- Employees
- 6, Dec 31, 2025
- Industry
- Services-Computer Programming, Data Processing, Etc.
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Weinberg & Company, P.A., Los Angeles, California
Stock & identifiers
- Ticker
- BRGX
- Exchange
- OTC
- IPO date
- Feb 15, 2002
- Shares outstanding
- 972M, May 20, 2026
- Public float
- $3.72M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-30 reverse, Mar 25, 2011; 1-for-100 reverse, Jul 8, 2010; 3-for-1, May 13, 2004; 1-for-15 reverse, Feb 27, 2004; 1-for-5 reverse, Oct 23, 2002; 1-for-3 reverse, Sep 19, 2002; 1-for-10 reverse, Feb 15, 2002
- SEC CIK
- 1593184
- EIN
- 46-2836541
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Richard Janney | Director | – |
Employees
Headcount reported in annual reports
“As of December 31, 2025, the Company and its subsidiaries employed six full-time employees and eight independent contractors.”
Corporate history
Events identified from SEC filings